Head and neck cancer: causes, types, diagnosis and treatment

Characteristics and pathology

Most head and neck cancers develop from the mucosal lining of these areas. Approximately 90% are squamous cell carcinomas, which originate in the surface epithelium. Tumor behavior, staging and treatment depend on the exact site, size, lymph node involvement and whether the disease has spread beyond local tissues.

Causes and risk factors

Key risk factors include tobacco use in its various forms and heavy alcohol consumption. Chewing or smokeless tobacco and smoking both raise risk, and their combined effect with alcohol further increases the chance of cancer. For example, long-term use of chewing tobacco and regular intake of alcohol are well-established contributors. Infection with certain strains of human papillomavirus (HPV) is a major cause of cancers in parts of the throat, especially in younger people and those without traditional tobacco or alcohol exposure.

Symptoms and diagnosis

Early disease may be symptomless or present with subtle signs. Common symptoms include persistent sore throat, hoarseness, a lump in the neck, non-healing ulcers in the mouth, difficulty swallowing, nasal blockage or unexplained bleeding. Diagnosis usually involves physical examination, endoscopic inspection, imaging (CT, MRI or PET), and biopsy for histological confirmation. Staging follows established clinical and pathological criteria to guide treatment planning.

Treatment and rehabilitation

Treatment choice depends on tumor site and stage. Major options include:

• Surgery to remove the primary tumor and affected lymph nodes.
• Radiation therapy, often used alone or after surgery.
• Chemotherapy and targeted systemic agents, used with radiation or for advanced disease.
• Reconstructive procedures and rehabilitative therapies for speech and swallowing.

Multidisciplinary care—combining head and neck surgeons, radiation and medical oncologists, speech therapists and dental specialists—improves outcomes and quality of life.

Prevention, prognosis and notable distinctions

Risk reduction focuses on stopping tobacco and limiting alcohol. HPV vaccination reduces the risk of virus-associated throat cancers. Prognosis varies widely: early-stage tumors can often be cured, while advanced or metastatic disease carries a poorer outlook. Important distinctions include differences between oral cavity cancers and those of the nasal cavity or sinuses in presentation and management, and the increasing proportion of HPV-related tumors in the oropharynx, which tend to respond differently to treatment.

Further reading and resources

For reliable background and patient information, see links to general resources and specialty pages: overview, lip, nasal cavity, paranasal sinuses, larynx, squamous cell carcinoma, epithelium, alcohol risks, chewing tobacco risks.

The information here summarizes broadly accepted clinical concepts and is intended for general understanding; individuals should consult healthcare professionals for personal advice.